Evolent Health A Aktie
8,80
EUR
-0,40
EUR
-4,35
%
9,91
USD
-0,16
USD
-1,59
%
Werbung
Evolent Health A Aktie Analyse
01.06.17 | Evolent Health A Outperform | Robert W. Baird & Co. Incorporated | |
13.07.16 | Evolent Health A Outperform | FBR Capital | |
29.03.16 | Evolent Health A Outperform | FBR Capital | |
06.01.16 | Evolent Health A Buy | Canaccord Adams |
Werbung
Werbung